Camille Shore

Camille Shore has a diverse and extensive work experience in the field of regulatory affairs. Camille started their career at Bachem California in 1988 and worked as an Associate Director until 2000. Camille then moved to Bachem Fine Chemicals and continued working in regulatory affairs until 2001. Camille then joined Amylin Pharmaceuticals as an Associate Director from 2000 to 2002. Camille later worked at PGRD, Pfizer as an Associate Director of Regulatory from 2002 to 2004. In 2003, they were an Associate Director at SkyePharma for a short period. Camille then worked at Biosensors International as a Director of Regulatory Affairs from 2007 to 2008, where they focused on regulatory input for various projects. Camille moved to San Francisco Bay Area in 2008 and worked as a Director of Regulatory for a short period. Later that year, they joined BaroFold Inc as a Director of Regulatory Affairs, and in 2009, they joined Versartis Inc as a Senior Director of Regulatory Affairs. In their current role, Camille is involved in international clinical trial design and implementation for early phase studies with new technologies.

Camille Shore attended Chapman University from 1970 to 1974. However, the degree name and field of study are not mentioned in the available information. Additionally, there is no specific information regarding Camille Shore's education history at UCLA.